{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:13:11Z","timestamp":1790712791986,"version":"4.1.0"},"reference-count":57,"publisher":"Oxford University Press (OUP)","issue":"1186","license":[{"start":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:00:00Z","timestamp":1784246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Radiation segmentectomy (RS) utilizing Yttrium-90 (Y90) microspheres has emerged as a highly effective, minimally invasive locoregional therapy for hepatocellular carcinoma (HCC), particularly in early-stage disease. This precision treatment delivers ablative radiation doses directly to the tumor and its immediate surrounding parenchyma, thereby minimizing systemic toxicity and preserving healthy liver tissue. RS consistently demonstrates high objective and complete response rates, which often correlate directly with complete pathological necrosis of the tumor, as rigorously assessed by the modified Response Evaluation Criteria in Solid Tumors and European Association for the Study of the Liver criteria. This robust imaging response translates into durable local tumor control and prolonged time to disease progression. The safety and feasibility of RS are generally well established. The procedure is typically well tolerated, with common adverse events usually being mild and transient. Severe complications are rare, emphasizing the procedure\u2019s precision and minimal invasiveness. Optimal outcomes are contingent upon meticulous patient selection, strict adherence to technical guidelines, and precise dosimetry. Beyond its role as a definitive therapy, RS plays a critical function in bridging and downstaging patients awaiting liver transplantation. By effectively controlling tumor burden, it enhances patient eligibility for transplantation and improves outcomes on transplant waiting lists. Furthermore, RS offers distinct advantages over other conventional locoregional therapies in specific clinical scenarios, solidifying its integral position within the comprehensive management paradigm for HCC.<\/jats:p>","DOI":"10.1093\/bjr\/tqag155","type":"journal-article","created":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:16:06Z","timestamp":1784315766000},"page":"2054-2064","source":"Crossref","is-referenced-by-count":0,"title":["Radiation segmentectomy for hepatocellular carcinoma: redefining the limits of curative-intent therapy"],"prefix":"10.1093","volume":"99","author":[{"given":"Elena","family":"Bozzi","sequence":"first","affiliation":[{"name":"Division of Interventional Radiology, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56124,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bianchi","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine Therapy for Endocrine and Oncological Diseases, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56126,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Lorenzoni","sequence":"additional","affiliation":[{"name":"Division of Interventional Radiology, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56124,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"MSc","given":"Alessia","family":"Giuliano","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56126,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Scalise","sequence":"additional","affiliation":[{"name":"Division of Interventional Radiology, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56124,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianvito","family":"Candita","sequence":"additional","affiliation":[{"name":"Division of Interventional Radiology, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56124,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"MSc","given":"Patrizio","family":"Barca","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56126,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Ambrosini","sequence":"additional","affiliation":[{"name":"Division of Interventional Radiology, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56124,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boni","sequence":"additional","affiliation":[{"name":"Division of Nuclear Medicine Therapy for Endocrine and Oncological Diseases, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56126,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"MSc","given":"Claudio","family":"Traino","sequence":"additional","affiliation":[{"name":"Department of Medical Physics, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56126,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cioni","sequence":"additional","affiliation":[{"name":"Division of Interventional Radiology, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56124,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8160-0483","authenticated-orcid":false,"given":"Laura","family":"Crocetti","sequence":"additional","affiliation":[{"name":"Division of Interventional Radiology, Azienda Ospedaliero Universitaria Pisana , Pisa, PI 56124,","place":["Italy"]},{"name":"Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa , Pisa, PI 56126,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,17]]},"reference":[{"key":"2026092915465169500_tqag155-B1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jhep.2024.08.028","article-title":"EASL clinical practice guidelines on the management of hepatocellular carcinoma","volume":"82","author":"European Association for the Study of the Liver","year":"2025","journal-title":"J Hepatol"},{"key":"2026092915465169500_tqag155-B2","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1007\/s00270-020-02471-z","article-title":"CIRSE standards of practice on thermal ablation of liver tumours","volume":"43","author":"Crocetti","year":"2020","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2026092915465169500_tqag155-B3","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.jhep.2025.01.005","article-title":"Radiation segmentectomy for early hepatocellular carcinoma is curative","volume":"82","author":"Salem","year":"2025","journal-title":"J Hepatol"},{"key":"2026092915465169500_tqag155-B4","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1097\/01.RVI.0000233785.75257.9A","article-title":"Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies. Part 1: technical and methodologic considerations","volume":"17","author":"Salem","year":"2006","journal-title":"J Vasc Interv Radiol"},{"key":"2026092915465169500_tqag155-B5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.jhep.2025.10.020","article-title":"BCLC strategy for prognosis prediction and treatment recommendations: the 2026 update","volume":"84","author":"Reig","year":"2026","journal-title":"J Hepatol"},{"key":"2026092915465169500_tqag155-B6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1097\/COC.0000000000000678","article-title":"Locoregional therapy protocols with and without radioembolization for hepatocellular carcinoma as bridge to liver transplantation","volume":"43","author":"Zori","year":"2020","journal-title":"Am J Clin Oncol"},{"key":"2026092915465169500_tqag155-B7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ejrad.2004.02.003","article-title":"The segments of the hepatic veins-is there a spatial correlation to the couinaud liver segments?","volume":"53","author":"Fischer","year":"2005","journal-title":"Eur J Radiol"},{"key":"2026092915465169500_tqag155-B8","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1055\/s-0041-1735529","article-title":"Radiation segmentectomy","volume":"38","author":"Prachanronarong","year":"2021","journal-title":"Semin Intervent Radiol"},{"key":"2026092915465169500_tqag155-B9","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.jvir.2019.12.017","article-title":"Increasing yttrium-90 dose conformality using proximal radioembolization enabled by distal angiosomal truncation for the treatment of hepatic malignancy","volume":"31","author":"Core","year":"2020","journal-title":"J Vasc Interv Radiol"},{"key":"2026092915465169500_tqag155-B10","doi-asserted-by":"publisher","first-page":"351","DOI":"10.21037\/hbsn-22-184","article-title":"Large, multifocal or portal vein-invading hepatocellular carcinoma (HCC) downstaged by Y90 using personalized dosimetry: safety, pathological results and outcomes after surgery","volume":"12","author":"Meerun","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"key":"2026092915465169500_tqag155-B11","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1007\/s00259-016-3438-x","article-title":"Same-day Y90 radioembolization: implementing a new treatment paradigm","volume":"43","author":"Gabr","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026092915465169500_tqag155-B12","doi-asserted-by":"publisher","first-page":"s555","DOI":"10.1007\/s00270-025-04245-x","article-title":"DOORwaY90: selective internal radiation therapy using SIR-Spheres Y-90 resin microspheres as first-line treatment for unresectable hepatocellular carcinoma patients\u2014an interim analysis","author":"Kappadath","year":"2026","journal-title":"CVIR"},{"key":"2026092915465169500_tqag155-B13","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3390\/curroncol31020045","article-title":"Radiation segmentectomy for hepatocellular carcinoma","volume":"31","author":"Serhal","year":"2024","journal-title":"Curr Oncol"},{"key":"2026092915465169500_tqag155-B14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S2468-1253(20)30290-9","article-title":"Personalised versus standard dosimetry approach of selective internal radiation therapy in patients with locally advanced hepatocellular carcinoma (DOSISPHERE-01): a randomised, multicentre, open-label phase 2 trial","volume":"6","author":"Garin","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026092915465169500_tqag155-B15","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.3390\/life13061238","article-title":"Single-compartment dose prescriptions for ablative 90Y-radioembolization segmentectomy","volume":"13","author":"Kappadath","year":"2023","journal-title":"Life"},{"key":"2026092915465169500_tqag155-B16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1055\/s-0041-1735571","article-title":"Radioembolization for the treatment of hepatocellular carcinoma: the road to personalized dosimetry and ablative practice","volume":"38","author":"De la Garza-Ramos","year":"2021","journal-title":"Semin Intervent Radiol"},{"key":"2026092915465169500_tqag155-B17","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1007\/s00259-021-05600-z","article-title":"EANM procedure guideline for the treatment of liver cancer and liver metastases with intra-arterial radioactive compounds","volume":"49","author":"Weber","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026092915465169500_tqag155-B18","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1007\/s00259-020-05163-5","article-title":"International recommendations for personalised selective internal radiation therapy of primary and metastatic liver diseases with yttrium-90 resin microspheres","volume":"48","author":"Levillain","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026092915465169500_tqag155-B19","volume-title":"MIRD Pamphlet No. 11: \u201cS,\u201d Absorbed Dose per Unit Cumulated Activity for Selected Radionuclides and Organs","author":"Snyder","year":"1975"},{"key":"2026092915465169500_tqag155-B20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.2967\/jnumed.108.056036","article-title":"MIRD pamphlet no. 21: a generalized schema for radiopharmaceutical dosimetry\u2014standardization of nomenclature","volume":"50","author":"Bolch","year":"2009","journal-title":"J Nucl Med"},{"key":"2026092915465169500_tqag155-B21","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.2967\/jnumed.122.264225","article-title":"MIRD pamphlet no. 28, part 1: MIRDcalc-a software tool for medical internal radiation dosimetry","volume":"64","author":"Kesner","year":"2023","journal-title":"J Nucl Med"},{"key":"2026092915465169500_tqag155-B22","doi-asserted-by":"publisher","first-page":"794","DOI":"10.2967\/jnumed.123.266743","article-title":"MIRD pamphlet no. 29: MIRDy90-a 90Y research microsphere dosimetry tool","volume":"65","author":"Marquis","year":"2024","journal-title":"J Nucl Med"},{"key":"2026092915465169500_tqag155-B23","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1055\/s-0041-1736660","article-title":"Beyond the MAA-Y90 paradigm: the evolution of radioembolization dosimetry approaches and scout particles","volume":"38","author":"Keane","year":"2021","journal-title":"Semin Intervent Radiol"},{"key":"2026092915465169500_tqag155-B24","doi-asserted-by":"publisher","first-page":"103172","DOI":"10.1016\/j.ejmp.2023.103172","article-title":"A single centre intercomparison between commercial treatment planning systems for 90Y radioembolization using virtual and experimental phantoms","volume":"116","author":"Della Gala","year":"2023","journal-title":"Phys Med"},{"key":"2026092915465169500_tqag155-B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/14736691211060117","article-title":"ICRU REPORT 96, dosimetry-guided radiopharmaceutical therapy","volume":"21","author":"Sgouros","year":"2021","journal-title":"J ICRU"},{"key":"2026092915465169500_tqag155-B26","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.3390\/app14031019","article-title":"The role of lung density in the voxel-based dosimetry of 90Y-TARE evaluated with the voxel S-value (VSV) method and fast monte carlo simulation","volume":"14","author":"Capotosti","year":"2024","journal-title":"Appl Sci"},{"key":"2026092915465169500_tqag155-B27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s40658-018-0221-z","article-title":"The physics of radioembolization","volume":"5","author":"Bastiaannet","year":"2018","journal-title":"EJNMMI Phys"},{"key":"2026092915465169500_tqag155-B28","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2967\/jnumed.112.105825","article-title":"Study of the impact of tissue density heterogeneities on 3-dimensional abdominal dosimetry: comparison between dose kernel convolution and direct monte carlo methods","volume":"54","author":"Dieudonne","year":"2013","journal-title":"J Nucl Med"},{"key":"2026092915465169500_tqag155-B29","doi-asserted-by":"publisher","first-page":"553","DOI":"10.2147\/JHC.S507267","article-title":"Radiation segmentectomy or ablative external beam radiation therapy as initial treatment for solitary hepatocellular carcinoma: a multicenter experience","volume":"12","author":"De la Garza-Ramos","year":"2025","journal-title":"J Hepatocell Carcinoma"},{"key":"2026092915465169500_tqag155-B30","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.jvir.2020.12.019","article-title":"Pathologic response of hepatocellular carcinoma treated with yttrium-90 glass microsphere radiation segmentectomy prior to liver transplantation: a validation study","volume":"32","author":"Toskich","year":"2021","journal-title":"J Vasc Interv Radiol"},{"key":"2026092915465169500_tqag155-B31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1055\/s-0030-1247132","article-title":"Modified RECIST (mRECIST) assessment for hepatocellular carcinoma","volume":"30","author":"Lencioni","year":"2010","journal-title":"Semin Liver Dis"},{"key":"2026092915465169500_tqag155-B32","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J Hepatol"},{"key":"2026092915465169500_tqag155-B33","doi-asserted-by":"crossref","first-page":"e2532745","DOI":"10.2214\/AJR.25.32745","article-title":"Radiation treatment response assessment version 2024: category redistribution and short-term outcomes in patients undergoing 90Y radioembolization for HCC","volume":"225","author":"Li-Rads Ct\/MRI","year":"2025","journal-title":"Am J Roentgenol"},{"key":"2026092915465169500_tqag155-B34","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1002\/hep.27057","article-title":"Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology pathology correlation and survival of radiation segmentectomy","volume":"60","author":"Vouche","year":"2014","journal-title":"Hepatology"},{"key":"2026092915465169500_tqag155-B35","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1002\/hep.31819","article-title":"Yttrium-90 radioembolization for the treatment of solitary, unresectable hepatocellular carcinoma: the LEGACY study","volume":"74","author":"Salem","year":"2021","journal-title":"Hepatology"},{"key":"2026092915465169500_tqag155-B36","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S2468-1253(22)00091-7","article-title":"Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER) a single-centre, single-arm study","volume":"7","author":"Kim","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"2026092915465169500_tqag155-B37","doi-asserted-by":"publisher","first-page":"e231386","DOI":"10.1148\/radiol.231386","article-title":"Efficacy and safety of radiation segmentectomy with 90Y resin microspheres for hepatocellular carcinoma","volume":"311","author":"Sarwar","year":"2024","journal-title":"Radiology"},{"key":"2026092915465169500_tqag155-B38","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.jvir.2017.02.018","article-title":"Segmental yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma: results of a single-center, retrospective, propensity score-matched study","volume":"28","author":"Padia","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"2026092915465169500_tqag155-B39","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00270-020-02712-1","article-title":"Evaluation of medium-term efficacy of Y90 radiation segmentectomy vs percutaneous microwave ablation in patients with solitary surgically unresectable &lt; 4 cm hepatocellular carcinoma: a propensity score matched study","volume":"44","author":"Arndt","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"2026092915465169500_tqag155-B40","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1016\/j.jvir.2022.03.021","article-title":"Radiation segmentectomy for the treatment of solitary hepatocellular carcinoma: outcomes compared with those of surgical resection","volume":"33","author":"De la Garza-Ramos","year":"2022","journal-title":"J Vasc Interv Radiol"},{"key":"2026092915465169500_tqag155-B41","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ijrobp.2009.10.062","article-title":"Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization","volume":"79","author":"Riaz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026092915465169500_tqag155-B42","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1148\/radiol.2018171768","article-title":"Radiation segmentectomy: potential curative therapy for early hepatocellular carcinoma","volume":"287","author":"Lewandowski","year":"2018","journal-title":"Radiology"},{"key":"2026092915465169500_tqag155-B43","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1007\/s00259-020-04976-8","article-title":"Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants","volume":"48","author":"Gabr","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2026092915465169500_tqag155-B44","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1097\/SLA.0000000000003253","article-title":"Pathologic response to pretransplant locoregional therapy is predictive of patient outcome after liver transplantation for hepatocellular carcinoma: analysis from the US multicenter HCC transplant consortium","volume":"271","author":"DiNorcia","year":"2020","journal-title":"Ann Surg"},{"key":"2026092915465169500_tqag155-B45","doi-asserted-by":"publisher","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"key":"2026092915465169500_tqag155-B46","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1016\/j.jvir.2009.05.030","article-title":"Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review","volume":"20","author":"Riaz","year":"2009","journal-title":"J Vasc Interv Radiol"},{"key":"2026092915465169500_tqag155-B47","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3348\/kjr.2022.0395","article-title":"Complications related to transarterial treatment of hepatocellular carcinoma: a comprehensive review","volume":"24","author":"Lee","year":"2023","journal-title":"Korean J Radiol"},{"key":"2026092915465169500_tqag155-B48","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1002\/hep.29691","article-title":"Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience","volume":"68","author":"Salem","year":"2018","journal-title":"Hepatology"},{"key":"2026092915465169500_tqag155-B49","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.cgh.2013.04.028","article-title":"Increased quality of life among hepatocellular carcinoma patients treated with radioembolization, compared with chemoembolization","volume":"11","author":"Salem","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2026092915465169500_tqag155-B50","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1097\/LVT.0000000000000589","article-title":"The 2024 ILTS-ILCA consensus recommendations for liver transplantation for HCC and intrahepatic cholangiocarcinoma","volume":"31","author":"Kodali","year":"2025","journal-title":"Liver Transpl"},{"key":"2026092915465169500_tqag155-B51","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1053\/j.gastro.2021.07.033","article-title":"Downstaging outcomes for hepatocellular carcinoma: results from the multicenter evaluation of reduction in tumor size before liver transplantation (MERITS-LT) consortium","volume":"161","author":"Mehta","year":"2021","journal-title":"Gastroenterology"},{"key":"2026092915465169500_tqag155-B52","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.2967\/jnumed.121.263147","article-title":"Long-term outcomes of transarterial radioembolization for large single hepatocellular carcinoma: a comparison to resection","volume":"63","author":"Kim","year":"2022","journal-title":"J Nucl Med"},{"key":"2026092915465169500_tqag155-B53","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1053\/j.gastro.2016.08.029","article-title":"Y90 radioembolization significantly prolongs time to progression compared with chemoembolization in patients with hepatocellular carcinoma","volume":"151","author":"Salem","year":"2016","journal-title":"Gastroenterology"},{"key":"2026092915465169500_tqag155-B54","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.jvir.2017.08.026","article-title":"Radiation segmentectomy versus selective chemoembolization in the treatment of early-stage hepatocellular carcinoma","volume":"29","author":"Biederman","year":"2018","journal-title":"J Vasc Interv Radiol"},{"key":"2026092915465169500_tqag155-B55","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1148\/radiol.211806","article-title":"90Y radioembolization versus drug-eluting bead chemoembolization for unresectable hepatocellular carcinoma: results from the TRACE phase II randomized controlled trial","volume":"303","author":"Dhondt","year":"2022","journal-title":"Radiology"},{"key":"2026092915465169500_tqag155-B56","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1148\/radiol.2016160718","article-title":"Radiation segmentectomy versus TACE combined with microwave ablation for unresectable solitary hepatocellular carcinoma up to 3 cm: a propensity score matching study","volume":"283","author":"Biederman","year":"2017","journal-title":"Radiology"},{"key":"2026092915465169500_tqag155-B57","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.2147\/JHC.S488138","article-title":"Radiofrequency ablation therapy versus stereotactic body radiation therapy for naive hepatocellular carcinoma (\u22645 cm): a retrospective multicenter study","volume":"11","author":"Sun","year":"2024","journal-title":"J Hepatocell Carcinoma"}],"container-title":["British Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjr\/advance-article-pdf\/doi\/10.1093\/bjr\/tqag155\/69201355\/tqag155.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/99\/1186\/2054\/69201355\/tqag155.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjr\/article-pdf\/99\/1186\/2054\/69201355\/tqag155.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:46:59Z","timestamp":1790711219000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjr\/article\/99\/1186\/2054\/8736935"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,17]]},"references-count":57,"journal-issue":{"issue":"1186","published-online":{"date-parts":[[2026,7,17]]},"published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1093\/bjr\/tqag155","relation":{},"ISSN":["0007-1285","1748-880X"],"issn-type":[{"value":"0007-1285","type":"print"},{"value":"1748-880X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,10]]},"published":{"date-parts":[[2026,7,17]]}}}